Communiqués DataMEDS AI, Inc.

Actions

MEDS

US9495032057

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 10/08/2026			Varia. 5j.	Varia. 1 janv.
1,600 ^USD	-19,60%		-50,62%	-91,99%

22/07	DataMEDS AI, Inc. changera son symbole boursier de WGRX à MEDS	CI
15/07	Wellgistics Health, Inc. nomme Brett Thompson au poste de Chief Technology Officer	CI

Communiqués

06/08	DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date	AQ
05/08	DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"	AQ
31/07	DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)	AQ
22/07	DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets	AQ
16/07	Rubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc.	AQ
15/07	Wellgistics Health Appoints Brett Thompson as Chief Technology Officer	AQ
30/06	Wellgistics Health Executive Chairman and President Exercise Warrants	AQ
26/06	DataMeds AI, Inc. Selected as Proposed New Name for Wellgistics Health, Inc.	AQ
01/06	Wellgistics Health Provides Mid-Year 2026 Corporate Outlook	AQ
28/05	Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock	AQ
27/05	Wellgistics Health Refinances Outstanding Convertible Debt and Raises $6.5M	AQ
26/05	Wellgistics Health Completes Reverse Split	AQ
21/05	CORRECTION FROM SOURCE: Wellgistics Health Releases Letter to Our Shareholders	AQ
21/05	Wellgistics Health Releases Letter to Our Shareholders	AQ
21/05	Wellgistics Health Announces Reverse Stock Split	AQ
19/05	Wellgistics Health Reports First Quarter 2026 Financials and Provides Business Update	AQ
15/05	Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026	AQ
14/05	Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program	AQ
13/05	Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services	AQ
14/04	Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives	AQ
23/03	Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders	AQ
19/03	Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share	AQ
13/03	Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction	AQ
02/02	Wellgistics Health : WGRX - Investor Presentation January 2026	PU
04/11	Wellgistics Health Enters into LOI to Acquire Kare Rx Hub	NE